Francis Burrows - Jan 28, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Scientific Officer
Signature
Teresa Bair, Attorney-in-fact for Francis Burrows
Stock symbol
KURA
Transactions as of
Jan 28, 2025
Transactions value $
-$17,051
Form type
4
Date filed
1/28/2025, 08:38 PM
Previous filing
Jan 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$6.66K -846 -3.7% $7.87 22K Jan 28, 2025 Direct F1
transaction KURA Common Stock Sale -$10.4K -1.32K -5.99% $7.87 20.7K Jan 28, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/21.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.